CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

DAA Combination for Elderly Patients With Chronic Hepatitis C

Published: Wed, 16 Aug 2017 12:00:00 EDT
This study aimed to assess the cost-effectiveness of direct-acting antivirals for the treatment of chronic hepatitis C in elderly patients. Which patients should be considered for treatment?
Liver International

Conversion From CNI to Everolimus After Kidney Transplant

Published: Wed, 16 Aug 2017 12:00:00 EDT
What benefits may converting from conventional CNI therapy to everolimus-based therapy offer kidney transplant patients?
American Journal of Transplantation

Assessment of Liver Fibrosis in Patients With Chronic HBV

Published: Wed, 16 Aug 2017 12:00:00 EDT
The authors compared the diagnostic performance of several biomarkers for the assessment of liver fibrosis in patients with chronic HBV infection.
Journal of Viral Hepatitis
Displaying results 4-6 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Lexicon builds case for Sanofi-partnered diabetes pill

Published: Tue, 15 Aug 2017 13:07:23 +0000
Lexicon Pharmaceuticals has bolstered the case for its Sanofi-partnered diabetes pill. The latest update means Lexicon now has data from two phase 3 trials showing the effect of the SGLT1-SGLT2 inhibitor sotagliflozin on A1C in patients with Type 1 diabetes is sustained over 52 weeks.

Cerecor CEO retires after scoring Johnson & Johnson license deal

Published: Tue, 15 Aug 2017 12:38:52 +0000
Shares in Cerecor leaped after the biotech licensed an antidepressant candidate to Johnson & Johnson, bringing in additional cash to advance its pipeline. The cash injection gives the Baltimore-based biotech operating cash through at least 2018.

ROS1 cancer patients set out to create disease models

Published: Tue, 15 Aug 2017 12:27:23 +0000
A group of cancer patients with the ROS1 mutation has teamed up with a nonprofit and a precision medicine company to create disease models. The collaboration aims to drive forward research into treatments for the rare ROS1 gene mutation by gathering tissue samples from patients.
Displaying results 4-6 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top